.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Accenture
Argus Health
Medtronic
Farmers Insurance
UBS
Deloitte
Mallinckrodt
Chinese Patent Office

Generated: September 26, 2017

DrugPatentWatch Database Preview

ISOCAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Isocaine Hydrochloride, and what generic Isocaine Hydrochloride alternatives are available?

Isocaine Hydrochloride is a drug marketed by Septodont Inc and is included in two NDAs.

The generic ingredient in ISOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.

Summary for Tradename: ISOCAINE HYDROCHLORIDE

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list59
Clinical Trials: see list2,276
Patent Applications: see list504
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ISOCAINE HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont Inc
ISOCAINE HYDROCHLORIDE
mepivacaine hydrochloride
INJECTABLE;INJECTION080925-001Approved Prior to Jan 1, 1982APRXNoYes► Subscribe► Subscribe► Subscribe
Septodont Inc
ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN
levonordefrin; mepivacaine hydrochloride
INJECTABLE;INJECTION084697-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Federal Trade Commission
McKesson
Julphar
Deloitte
Covington
Johnson and Johnson
Chinese Patent Office
Fuji
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot